Company / R&D Expense
SI-BONE, Inc. R&D Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$17.4M
FY2025
5-year range
$12.4M / $17.4M
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
#94 of 105
Health Care
What the data says
Among 105 Health Care companies, SI-BONE, Inc. is in the bottom 10% for r&d expense. R&D Expense has increased for 7 consecutive years, from $5M in FY2018 to $17M in FY2025.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of +13.0%.
Improved from $15M to $17M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +8.6%
- 5-Year CAGR
- +13.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 105This company $17.4M Sector average $284.2M
▼
-93.9% below sector average
Key checks
Key Insights
- SI-BONE, Inc.'s r&d expense has grown for 7 consecutive years.
- 5-year CAGR of +13.0%, indicating consistent growth.
- In FY2025, r&d expense increased 5.4% year-over-year.
- Ranks #94 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.4M | +5.4% |
| FY2024 | $16.6M | +10.2% |
| FY2023 | $15.0M | +10.3% |
| FY2022 | $13.6M | +9.5% |
| FY2021 | $12.4M | +31.5% |
| FY2020 | $9.5M | +29.9% |
| FY2019 | $7.3M | +35.4% |
| FY2018 | $5.4M | -2.5% |
| FY2017 | $5.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026